US HR242 | 2019-2020 | 116th Congress
Status
Spectrum: Slight Partisan Bill (Democrat 5-2)
Status: Introduced on March 18 2019 - 25% progression, died in committee
Action: 2019-03-19 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 18 2019 - 25% progression, died in committee
Action: 2019-03-19 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
This resolution applauds the growth in research and development into new therapies for rare diseases and recognizes that significant research and development efforts and related investments are needed to develop therapies to treat and cure thousands of rare diseases for which no treatment options are currently available.
Title
Affirming the importance of the Orphan Drug Act, celebrating the over 750 new orphan therapies approved since its creation, and recognizing the need to continue supporting research and development for rare diseases.
Sponsors
| Rep. G. Butterfield [D-NC] | Rep. Gus Bilirakis [R-FL] | Rep. Bill Flores [R-TX] | Rep. Suzanne Lee [D-NV] |
| Rep. Sanford Bishop [D-GA] | Rep. John Yarmuth [D-KY] | Rep. Joseph Neguse [D-CO] |
History
| Date | Chamber | Action |
|---|---|---|
| 2019-03-19 | House | Referred to the Subcommittee on Health. |
| 2019-03-18 | House | Referred to the House Committee on Energy and Commerce. |
| 2019-03-18 | House | Introduced in House |
Subjects
Congressional tributes
Drug safety, medical device, and laboratory regulation
Drug therapy
Health
Health care costs and insurance
Health care coverage and access
Health care quality
Health promotion and preventive care
Medical research
Prescription drugs
Research and development
Drug safety, medical device, and laboratory regulation
Drug therapy
Health
Health care costs and insurance
Health care coverage and access
Health care quality
Health promotion and preventive care
Medical research
Prescription drugs
Research and development
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/116th-congress/house-resolution/242/all-info |
| Text | https://www.congress.gov/116/bills/hres242/BILLS-116hres242ih.pdf |
